TIAA CREF Investment Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

TIAA CREF Investment Management’s Portfolio MLNT Stock Details MLNT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$53K	Buy
2018 Q4	$28K	Sell
2018 Q3	$358K	Buy
2018 Q2	$465K	Buy
2018 Q1	$178K	Sell
2017 Q4	$1.22M	Buy